IGeneX Revenue and Competitors
Estimated Revenue & Valuation
- IGeneX's estimated annual revenue is currently $12.9M per year.
- IGeneX's estimated revenue per employee is $243,000
Employee Data
- IGeneX has 53 Employees.
- IGeneX grew their employee count by 0% last year.
IGeneX's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Marketing | Reveal Email/Phone |
2 | Program Manager & Financial Data Analyst | Reveal Email/Phone |
3 | Sales Representative | Reveal Email/Phone |
4 | National Sales Manager | Reveal Email/Phone |
5 | Senior Research Associate | Reveal Email/Phone |
6 | Marketing Associate | Reveal Email/Phone |
7 | QA | Reveal Email/Phone |
8 | Billing Clerk | Reveal Email/Phone |
9 | Medical Billing Specialist | Reveal Email/Phone |
10 | Sales Representative - Midwest | Reveal Email/Phone |
IGeneX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.3M | 59 | 9% | N/A | N/A |
#2 | $179.6M | 532 | 7% | N/A | N/A |
#3 | $6.5M | 30 | 3% | N/A | N/A |
#4 | $5.3M | 28 | -3% | N/A | N/A |
#5 | $12.4M | 51 | 28% | N/A | N/A |
#6 | $13.6M | 56 | -10% | N/A | N/A |
#7 | $6.5M | 30 | -12% | N/A | N/A |
#8 | $18M | 74 | 6% | N/A | N/A |
#9 | $10.2M | 47 | 2% | N/A | N/A |
#10 | $181.6M | 538 | 13% | N/A | N/A |
What Is IGeneX?
For over 25 years, IGeneX has been at the forefront of Lyme disease and other tick-borne related illnesses. The company has not only made a profound impact on how these diseases get diagnosed more accurately with their testing diagnostics, it has also been instrumental in training physicians to better understand tick-borne diseases and become Lyme literate.
keywords:N/AN/A
Total Funding
53
Number of Employees
$12.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7M | 54 | N/A | N/A |
#2 | $7.2M | 55 | 2% | N/A |
#3 | $7.2M | 55 | 57% | N/A |
#4 | $7.2M | 55 | 28% | N/A |
#5 | $7.2M | 55 | -11% | N/A |